(MENAFNEditorial) iCrowdNewswire - Oct 12, 2018
Bird Flu Treatment Market 2018
Bird flu is a viral infection caused by avian influenza A viruses in birds. The viruses that cause the disease in birds can mutate and spread to humans. Bird flu is named H or N depending on the protein found on the surface of the virus. Out of the three types of influenza viruses (A, B, and C), influenza A virus causes zoonotic infection. Influenza virus A is categorized into types based on surface proteins hemagglutinin (HA) and neuraminidase. Based on origin, the influenza A virus can be classified into avian influenza, swine influenza, and others types of animal influenza viruses. Avian influenza primarily spreads to people through direct contact with infected poultry.
Rise in outbreaks of avian influenza in the poultry industry and awareness about diagnosis among infected patients are projected to drive the bird flu treatment market during the forecast period. However, resistance of the virus to existing anti-viral drugs is projected to restrain the bird flu treatment market in the coming years.
In 2017, the global Bird Flu Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Bird Flu Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bird Flu Treatment development in United States, Europe and China.
Request a Sample Report @ https://www.wiseguyreports.com/reports/3457435-global-bird-flu-treatment-market-size-status-and-forecast-2018-2025
The key players covered in this study
Sanofi
Roche
GlaxoSmithKline
Pfizer
Cipla
Abbott
BioCryst Pharmaceuticals
Forrest Pharmaceuticals
Gilead Sciences
Macleods Pharmaceuticals
Sinovac Biotech
Market segment by Type, the product can be split into
Antibiotics
Vaccines
Antiviral Agents
Immunoglobulins
Market segment by Application, split into
Hospitals
Clinics
Institutional Health Centers
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Complete Report Details @ https://www.wiseguyreports.com/reports/3457435-global-bird-flu-treatment-market-size-status-and-forecast-2018-2025
Table of Contents Analysis of Key Points
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bird Flu Treatment Market Size Growth Rate by Type (2013-2025)
1.4.2 Antibiotics
1.4.3 Vaccines
1.4.4 Antiviral Agents
1.4.5 Immunoglobulins
1.5 Market by Application
1.5.1 Global Bird Flu Treatment Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Institutional Health Centers
1.5.5 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bird Flu Treatment Market Size
2.2 Bird Flu Treatment Growth Trends by Regions
2.2.1 Bird Flu Treatment Market Size by Regions (2013-2025)
2.2.2 Bird Flu Treatment Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bird Flu Treatment Market Size by Manufacturers
3.1.1 Global Bird Flu Treatment Revenue by Manufacturers (2013-2018)
3.1.2 Global Bird Flu Treatment Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Bird Flu Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Bird Flu Treatment Key Players Head office and Area Served
3.3 Key Players Bird Flu Treatment Product/Solution/Service
3.4 Date of Enter into Bird Flu Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
…….
12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bird Flu Treatment Introduction
12.1.4 Sanofi Revenue in Bird Flu Treatment Business (2013-2018)
12.1.5 Sanofi Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bird Flu Treatment Introduction
12.2.4 Roche Revenue in Bird Flu Treatment Business (2013-2018)
12.2.5 Roche Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bird Flu Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Bird Flu Treatment Business (2013-2018)
12.3.5 GlaxoSmithKline Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bird Flu Treatment Introduction
12.4.4 Pfizer Revenue in Bird Flu Treatment Business (2013-2018)
12.4.5 Pfizer Recent Development
12.5 Cipla
12.5.1 Cipla Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bird Flu Treatment Introduction
12.5.4 Cipla Revenue in Bird Flu Treatment Business (2013-2018)
12.5.5 Cipla Recent Development
12.6 Abbott
12.6.1 Abbott Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bird Flu Treatment Introduction
12.6.4 Abbott Revenue in Bird Flu Treatment Business (2013-2018)
12.6.5 Abbott Recent Development
12.7 BioCryst Pharmaceuticals
12.7.1 BioCryst Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bird Flu Treatment Introduction
12.7.4 BioCryst Pharmaceuticals Revenue in Bird Flu Treatment Business (2013-2018)
12.7.5 BioCryst Pharmaceuticals Recent Development
Continued…..
CONTACT US:
Norah Trent
Partner Relations & Marketing Manager
[email protected]
www.WiseGuyReports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Contact Information:
Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
MENAFN1210201800703403ID1097561156
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.